tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jaguar Health Risks Nasdaq Delisting Over Low Stock Price

Jaguar Health Risks Nasdaq Delisting Over Low Stock Price

Jaguar Animal Health (JAGX) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Jaguar Health, Inc. is on the brink of being delisted from the Nasdaq as its stock price has failed to meet the minimum $1.00 requirement for an extended period. Despite receiving grace periods to rectify the issue, the company’s stock has continued to plummet, currently trading at $0.10 or less. The company faces delisting effective February 26, 2024, but has the chance to appeal before then. Amidst this precarious situation, Jaguar Health is considering all available options to regain compliance and maintain its listing, but there is no guarantee of success.

For further insights into JAGX stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1